Skip to content

Clinical trials

Sexually Transmitted Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sexually Transmitted Diseases Country / region: France Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20131
20151
20161
20181
20193
20211
20222
20234
20242
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Not yet recruiting2
Recruiting2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ANRS, Emerging Infectious Diseases2
Assistance Publique - Hôpitaux de Paris2
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba2
Assistance Publique Hopitaux De Marseille1
Central Hospital, Nancy, France1
Centre Hospitalier Régional d'Orléans1
Centre National de la Recherche Scientifique, France1
Centre de santé sexuelle Le 1901
French National Agency for Research on AIDS and Viral Hepatitis1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sexually Transmitted Diseases20
HIV Infections6
Acquired Immunodeficiency Syndrome4
Gonorrhea3
Hepatitis2
Infections2
Syphilis2
Asymptomatic Infections1
Bacterial Infections1
Chlamydia Infections1

Trials

Showing 76 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.